0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Jorge Huaco Cateriano, MD; Kenneth W. Gow, MD
Arch Surg. 2011;146(5):629. doi:10.1001/archsurg.2011.107-a.

Special Feature |  FREE
Cheng-Maw Ho, MD; Po-Huang Lee, MD, PhD
Arch Surg. 2007;142(12):1219. doi:10.1001/archsurg.142.12.1219.

Special Feature |  FREE
Arch Surg. 2007;142(12):1220. doi:10.1001/archsurg.142.12.1220.

Moments in Surgical History | 
Irvin M. Modlin, MD, PhD; Michael D. Shapiro, MD; Mark Kidd, PhD; et al.
Arch Surg. 2007;142(2):187-197. doi:10.1001/archsurg.142.2.187.

Moments in Surgical History | 
Ira M. Rutkow, MD, MPH, DrPH
Arch Surg. 2001;136(1):119. doi:10.1001/archsurg.136.1.119.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Pediatrics
Editorial  | 
Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents
Ben J. Marais, PhD
JAMA Pediatrics
Original Investigation  | 
Treatment for Preventing Tuberculosis in Children and Adolescents:  A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.
JAMA Dermatology
Notable Notes  | 
The Multifarious Adirondack Chair
Megan E. MacGillivray, MD(C)
JAMA
Clinical Trials Update  | 
TB Regimens: Less Is Not More
Anita Slomski, MA